ASYMCHEM：2025FIRSTQUARTERLYREPORT.pdf

1、1Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in relia

2、nce upon the whole or any part of the contents of this announcement.Asymchem Laboratories(Tianjin)Co.,Ltd.凱萊英醫藥集團(天津)股份有限公司(A joint stock company incorporated in the Peoples Republic of China with limited liability)(Stock Code:6821)2025 FIRST QUARTERLY REPORTThis announcement is made by Asymchem Lab

3、oratories(Tianjin)Co.,Ltd.(凱萊英醫藥集團(天津)股份有限公司)(the“Company”and together with its subsidiaries,the“Group”)pursuant to Rules 13.09 and 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited(the“Listing Rules”)and the Inside Information Provisions(as defined i

4、n the Listing Rules)under Part XIVA of the Securities and Futures Ordinance(Chapter 571 of the Laws of Hong Kong).Reference is made to the“Asymchem Laboratories(Tianjin)Co.,Ltd.2025 Quarterly Report for the First Quarter”published by the Company on the website of the Shenzhen Stock Exchange,for refe

5、rence purpose only.The first quarterly report for 2025 of the Company(the“2025 First Quarterly Report”)is written in both Chinese and English.In the case of any discrepancies,the Chinese version of the report shall prevail.The board(the“Board”)of directors(the“Directors”)of the Company reminds share

6、holders and potential investors of the Company that the information and financial data set out in this announcement are unaudited,have been reviewed by the audit committee of the Company,but have not been reviewed by the independent auditors of the Company.The unaudited financial data in the 2025 Fi